A Case Report for a Korean Patient with Mucopolysaccharidosis IIIA Confirmed by Biochemical and Molecular Genetic Investigation

Mucopolysaccharidosis (MPS) IIIA is a lysosomal storage disorder caused by abnormalities of the enzyme Heparan N-sulfatase that is required for degradation of heparan sulfate. The patient in this study was a 5 year-old boy who presented with macrocephaly and developmental delay. Urinary excretion of glycosaminoglycan was increased (26 g/moL creatinine, reference range: T (p.S347F) and c.703G>A (p.D235N). This is the first report for a Korean patient with MPS IIIA who was confirmed by biochemical investigation and molecular genetic analyses.

[1]  L. Gort,et al.  Natural history of Sanfilippo syndrome in Spain , 2013, Orphanet Journal of Rare Diseases.

[2]  C. Ki,et al.  A Novel Mutation (c.200T>C) in the NAGLU Gene of a Korean Patient with Mucopolysaccharidosis IIIB , 2013, Annals of laboratory medicine.

[3]  C. Ki,et al.  The First Korean Case of Mucopolysaccharidosis IIIC (Sanfilippo Syndrome Type C) Confirmed by Biochemical and Molecular Investigation , 2012, Annals of laboratory medicine.

[4]  W. Hwu,et al.  Incidence of the mucopolysaccharidoses in Taiwan, 1984–2004 , 2009, American journal of medical genetics. Part A.

[5]  T. Braulke,et al.  Scoring Evaluation of the Natural Course of Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A) , 2007, Pediatrics.

[6]  L. Jenkinson,et al.  Quantitation of urinary glycosaminoglycans using dimethylene blue as a screening technique for the diagnosis of mucopolysaccharidoses - an evaluation , 2007, Annals of clinical biochemistry.

[7]  Jeehun Lee,et al.  Clinical and Laboratory Features of Korean Mucopolysaccharidoses (MPSs) , 2005 .

[8]  O. Gabrielli,et al.  An adult Sanfilippo type A patient with homozygous mutation R206P in the sulfamidase gene , 2005, American journal of medical genetics. Part A.

[9]  N. Masuda,et al.  An adult Japanese Sanfilippo A patient with novel compound heterozygous S347F and D444G mutations in the sulphamidase gene , 2002, Journal of neurology, neurosurgery, and psychiatry.

[10]  M. Kimura,et al.  Molecular analysis of the α-N-acetylglucosaminidase gene in seven Japanese patients from six unrelated families with mucopolysaccharidosis IIIB (Sanfilippo type B), including two novel mutations , 2002, Journal of Human Genetics.

[11]  Chieh-Wen Shen,et al.  Identification and characterization of mutations underlying Sanfilippo syndrome type A (mucopolysaccharidosis type IIIA) , 2002, Clinical genetics.

[12]  J. Hopwood,et al.  Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications , 2001, Human mutation.

[13]  J. Hopwood,et al.  Heparan N-sulfatase gene: two novel mutations and transient expression of 15 defects. , 2000, Biochimica et biophysica acta.

[14]  J. Hopwood,et al.  Novel mutations in Sanfilippo A syndrome: implications for enzyme function. , 1997, Human molecular genetics.

[15]  J. E. Wraith,et al.  Management of mucopolysaccharidosis type III. , 1993 .

[16]  R. Wevers,et al.  Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue. , 1992, Clinical chemistry.

[17]  B. Poorthuis,et al.  Sanfilippo syndrome: A mini-review , 2008, Journal of Inherited Metabolic Disease.

[18]  S. Esposito,et al.  Identification of molecular defects in Italian Sanfilippo A patients including 13 novel mutations , 1998, Human mutation.

[19]  D. Grinberg,et al.  Mutation 1091delC is highly prevalent in Spanish Sanfilippo syndrome type A patients , 1998, Human mutation.

[20]  J. Hopwood,et al.  Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A) , 1997, Human mutation.